• ¹⁸F-AlF-NOTA-octreotide PET/CT in the localization of tumor-induced osteomalacia: case series and literature review
• A Case of Rickets and Pediatric Iron Deficiency Anemia in Alabama
• A de novo PRPF8 Pathogenic Variant in Transient Severe Hypophosphatemia with Delayed Puberty and Growth Failure
• A Mild Presentation of X-Linked Hypophosphatemia Caused by a Non-Canonical Splice Site Variant in the <em>PHEX</em> Gene
• A Phosphaturic Mesenchymal Tumor Presenting as Reversible Metabolic Myopathy
• A Rare Association Between Osteomalacia, Phosphaturic Mesenchymal Tumor, and Ovarian Cancer: A Case Report and Literature Review
• A toddler with severe vitamin D-dependent rickets type 1 A (VDDR1A), hungry bone syndrome, and severe RSV infection: presentation and therapeutic challenges
• Activin A: a marker of mineral bone disorder in children with chronic kidney disease?
• Adaptation of the Coparenting Relationship Scale Questionnaire to Spanish Parents with Offspring
• Alteration of bone microarchitecture in hereditary distal RTA patients with SLC4A1 gene mutation: assessed by HR-pQCT
• An image of a FGF-23-producing tumor resulting in osteomalacia
• Arthrogryposis, renal dysfunction, cholestasis syndrome with a novel mutation in two siblings
• Autosomal Recessive Hypophosphatemic Rickets Type 2 Associated with a Novel ENPP1 Variant in a Taiwanese Girl
• Bilateral Femoral Neck Fractures in a 50-Year-Old Patient with Chronic Kidney Disease
• Biosynthesis of calcifediol and calcitriol: a review
• Burosumab Efficacy and Safety in Patients with X-Linked Hypophosphatemia: Systematic Review and Meta-analysis of Real-World Data
• Burosumab treatment of X-linked hypophosphatemia patients: interim analysis of the SUNFLOWER longitudinal, observational cohort study
• Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period
• Cardiovascular health in pediatric patients with X-linked hypophosphatemia under two years of burosumab therapy
• Challenges in Hypophosphatasia: Suspicion, Diagnosis, Genetics, Management, and Follow-Up
• Clinical characteristics and genetic profile of children with WDR72-associated distal renal tubular acidosis: a nationwide experience
• Clinical characteristics and long-term management for patients with vitamin D-dependent rickets type II: a retrospective study at a single center in Saudi Arabia
• Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose
• Coexistence of hypogonadotropic hypogonadism and hypophosphatemic rickets
• Commentary on: Assessing diagnostic certainty for scurvy and rickets in human skeletal remains - An update on Brickley and Morgan (2023)
• Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience
• Complex phenotype in Fanconi renotubular syndrome type 1: Hypophosphatemic rickets as the predominant presentation
• Consenso mexicano de tirosinemia tipo 1
• CYP4A22 loss-of-function causes a new type of vitamin D-dependent rickets (VDDR1C)
• Cystinosis-associated metabolic bone disease across ages and CKD stages 1-5D/T
• Daily versus fortnightly oral vitamin D₃ in treatment of symptomatic vitamin D deficiency in children aged 1-10 years: An open labelled randomized controlled trial
• Debilitating Musculoskeletal Disease in Two Free-Ranging Juvenile American Black Bears (<em>Ursus americanus</em>)
• Deletion of vitamin D receptor exacerbated temporomandibular joint pathological changes under abnormal mechanical stimulation
• Diagnosis, treatment, and management of rickets: a position statement from the Bone and Mineral Metabolism Group of the Italian Society of Pediatric Endocrinology and Diabetology
• Dr Catherine Chisholm, 'children's physician': Her work for child welfare and feminist networking in Manchester
• Early manifestation of hypophosphatemic rickets in goslings: a potential role of insufficient muscular adenosine triphosphate in motility impairment of early P-deficient geese
• Effect and safety of Burosumab in the treatment of 4 children with X-linked hypophosphatemia
• Efficacy and safety of burosumab compared with conventional therapy in patients with X-linked hypophosphatemia: A systematic review
• Erratum to "An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH)." Kidney International 2023;105:1058-1076
• Establishing a human-induced pluripotent stem cell line SMUSHi005-A from a patient with hypophosphatemic vitamin D-resistant rickets carrying the PHEX c.1586-1586+1 delAG mutation
• Etiology and Biochemical Profile of Rickets in Tertiary Care Centres in Eastern India: A Retrospective Cross-sectional Study
• Evaluation of bone density and microarchitecture in adult patients with X-linked hypophosphatemic rickets: A pilot longitudinal study
• Evaluation of dental manifestations in X-linked hypophosphatemia using orthopantomography
• Exploring the Interplay between Vitamin D, Insulin Resistance, Obesity and Skeletal Health
• Fat-Soluble Vitamins A, D, E, and K: Review of the Literature and Points of Interest for the Clinician
• Fate and preservation of the late pleistocene cave bears from Niedźwiedzia Cave in Poland, through taphonomy, pathology, and geochemistry
• FGF23-secreting sinonasal tumour presenting with acute subdural haemorrhage and tumour-induced osteomalacia
• Hereditary hypophosphatemic rickets with hypercalciuria (HHRH), a complex disorder in need of precision medicine
• Hereditary tyrosinaemia type 1 in the absence of succinylacetone: 4-oxo 6-hydroxyhepanoate (4OHHA), a putative diagnostic biomarker
• Hereditary vitamin D resistant rickets (HVDRR) case series: phenotype, genotype, conventional treatment, and adjunctive cinacalcet therapy
• Heterogeneity in experiences of vitamin D deficiency in an early to mid-19th century population from Montreal, Quebec
• High prevalence of adult and nonadult scurvy in an early agricultural transition site from Mainland Southeast Asia was associated with decreased survivorship
• Hypophosphatemic rickets and short stature
• Increased blood 1,25 dihydroxyvitamin D levels in infants with Metabolic Bone Disease of Infancy in contested cases of child abuse
• Insight into the potential of bone turnover biomarkers: integration in the management of osteoporosis and chronic kidney disease-associated osteoporosis
• Knowledge and attitude of spouses of puerperas towards breastfeeding
• Lessons learned from the real-world diagnosis and management of hereditary hypophosphatemic rickets
• Leveraging quantitative systems pharmacology and artificial intelligence to advance treatment of chronic kidney disease mineral bone disorder
• LGR signaling mediates muscle-adipose tissue crosstalk and protects against diet-induced insulin resistance
• Long-Term Follow-Up Data of Tumor-Induced Osteomalacia Managed with Surgery and/or Radiofrequency Ablation from a Single Center
• Longitudinal analysis of vitamin D levels considering sunshine duration and suggestion for a standardised approach for vitamin D supplementation in children and adolescents with obesity
• Maternal Vitamin D Supplementation and Infantile Rickets: Secondary Analysis of a Randomized Trial
• Metabolic Bone Disease
• Metabolically healthy obesity in adults with X-linked hypophosphatemia
• Metaphyseal anadysplasia type 1: Familial and regressive rickets manifestation
• Mitochondrial Dysfunction, Oxidative Stress and Premature Aging in Children With Nutritional Rickets
• Morphological changes and their associations with clinical parameters in children with nephropathic cystinosis and chronic kidney disease prior to kidney replacement therapy over 25 years
• New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province
• NFATc1 Is Required for Vitamin D- and Phosphate-Mediated Regulation of Osteocyte Lacuno-Canalicular Remodeling
• Non-Surgical Strategies for Managing Skeletal Deformities in a Child with X-Linked Hereditary Hypophosphatemic Ricket: Insights and Perspectives
• Optimisation of vitamin D status in global populations
• Orthopedic Surgical Treatment of Patients with Tumor-induced Osteomalacia Located in the Hip Bones: A Retrospective Analysis of 10 Years in a Single Center
• OSTEOPROTEGERIN AS AN EARLY SIGN OF CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER
• Pediatric hypophosphatasia: avoid diagnosis missteps!
• Phenotypes of Mineral Bone Disorder in Chronic Kidney Disease in a Dialysis Population
• Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report
• Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders
• Retrospective study on the diagnosis, treatment, and follow-up of 85 cases of hypophosphatemic rickets in children
• Risk factors and outcomes of vitamin D deficiency in very preterm infants
• Safety and efficacy of burosumab in improving phosphate metabolism, bone health, and quality of life in adolescents with X-linked hypophosphatemic rickets
• Siblings with vitamin D-dependent rickets type 1A: Importance of genetic testing and a review of genotype-phenotype correlations
• Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease
• Sulfated vitamin D metabolites represent prominent roles in serum and in breastmilk of lactating women
• Surgical outcome of angular deformity correction of lower limbs in rickets: a cross-sectional study
• The 100 top-cited articles on chronic kidney disease-mineral and bone disorder: A bibliometric analysis
• The Non-conventional Effects of Hypovitaminosis D: A Pandemic Even in Sunlight-Rich Countries
• The role of GDF5 in regulating enthesopathy development in the Hyp mouse model of XLH
• The Role of Intestinal Cytochrome P450s in Vitamin D Metabolism
• Threshold for increased liver weight is protective of other effects in peromyscus exposed to PFNA
• Tumor-induced osteomalacia: A systematic literature review
• Tumour-induced osteomalacia: the long road to diagnosis and recovery
• Unmeasurable low vitamin D levels caused by a novel, homozygote loss-of-function variant in the group-specific component gene
• Unusual presentation of Sjogren's syndrome
• Variable presentation and outcomes of primary hyperparathyroidism in children and adolescents
• Vitamin D and bone health: What vitamin D can and cannot do
• Vitamin D deficiency and chronological hypoplasia with hypomineralisation: a case report
• Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline
• Vitamin D, the Sunshine Molecule That Makes Us Strong: What Does Its Current Global Deficiency Imply?
• Vitamin D: Analytical Advances, Clinical Impact, and Ongoing Debates on Health Perspectives
• X-linked hypophosphatemic rickets and nephrocalcinosis: clinical characteristics of a single-center pediatric cohort in North America before and after burosumab